Vakuum-behandling av sår
Vakuumbehandling av sår
Hjelper med å håndtere forskjellige sår
Innen sårbehandling er det viktig å behandle hver pasient unikt, da ingen sår er like. Vakuumbehandling av sår (NPWT), et gjennombrudd innen sårbehandling, tilbyr en innovativ tilnærming til personlig behandling ved å skape et miljø som fremmer sårheling. Ved å tilføre kontinuerlig eller periodisk sub-atmosfærisk trykk, hjelper NPWT med å fjerne eksudat og infeksiøse materialer fra sårbunnen, redusere ødem og fremme blodgjennomstrømming i vev og dannelse av granulasjonsvev.
Vi tilbyr en rekke NPWT-løsninger for å hjelpe pasienter gjennom hele behandlingsforløpet. Våre løsninger har i sammenlignende kliniske studier vist å kunne redusere behandlingskostnader og forbedre resultatene for pasienter.3-5
Typer av sår
Vår omfattende NPWT-portefølje hjelper til med å fremme heling av ulike sårtyper og gjennom alle nivåer av pleie, inkludert, men ikke begrenset til:
Din partner for pålitelige, trygge NPWT-løsninger
Å velge et sårbehandlingssystem er en viktig beslutning. Som din partner i sårbehandling er vi forpliktet til å tilby løsninger som støtter pasientenes sårheling gjennom hele behandlingsreisen. Utforsk våre velprøvde løsninger.
Støtte klinikere kan stole på
Du trenger mer en kun et produkt. Du trenger en betrodd partner. Fra start til utskrivelse er vi her for å hjelpe deg, ditt team og dine pasienter med løsninger, kundestøtte og ressurser for å veilede deg hvert skritt på veien.
Vi kan tilby deg:
Dokumenterte løsninger
Vår omfattende portefølje av avanserte løsninger for sårbehandling er støttet av kliniske studier på tvers av nye og voksende kategorier— inkludert bandasjer, engangsprodukter, digital teknologi og tilkobling.
Ressurser i verdensklasse
Få tilgang til gratis, live og forespurte webinarer for å utdype din kunnskap om sårbehandling og og for å forbedre pleien og resultatet for pasienten.
Utforsk mer
Indikasjon(er) for bruk / Tiltenkt bruk: Godkjent av US FDA: Gjelder kun for i USA:
Prevena Dressing used with Prevena Therapy Units: PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible PREVENA™ dressings for up to seven days, PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units are intended to aid in reducing the incidence of seroma; and in patients at high risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and Class II wounds.
Limitations:
- The device is not intended to treat surgical site infection or seroma.
- Safety and effectiveness in pediatric population (<22 years old) have not been evaluated.
- Safety and effectiveness in Class III (Contaminated) and Class IV (Dirty/Infected) wounds have not been demonstrated. Furthermore, Class IV surgical wounds are not expected to be closed primarily, and the subject device should only be used on closed surgical incisions.
- The device has not been demonstrated to reduce deep incisional and organ space surgical site infections.
- The device has not been demonstrated to be effective in reducing the incidence of surgical site infection and seroma in all surgical procedures and patient populations; therefore, the device may not be recommended for routine use to reduce the incidence of surgical site infection and seroma.
- Please refer to the ‘Summary of Clinical Information’ section for the specific surgical procedures and patient populations included in the clinical studies. Surgeons should continue to follow the ‘Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection’11 and the ‘American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines’12 for best practices in preventing surgical site infection. US FDA Cleared: Dressings/ Systems (Prevena Dressings used with compatible Solventum NPWT units - ActiVAC, Ulta, and RX4) and applicable OUS countries that leverage US Indication: The PREVENA™, PREVENA PLUS™, PREVENA DUO™, and PREVENA RESTOR™ Incision Management Systems are intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy.
Referanser:
- KCI. Cumulative NPWT Wounds—10 million. 2013-2015. Internal Report (v1.0). 2018.
- KCI. Percentage of V.A.C. Therapy Articles vs. Comp Articles. May 7, 2020
- Yang CK, Alcantara S, Goss S, Lantis JC 2nd. Cost analysis of negative-pressure wound therapy with instillation for wound bed preparation preceding split-thickness skin grafts for massive (>100 cm(2)) chronic venous leg ulcers. J Vasc Surg. 2015 Apr;61(4):995-9.
- Law A, Cyhaniuk A, Krebs B. Comparison of health care costs and hospital readmission rates associated with negative pressure wound therapies. Wounds. 2015 Mar;27(3):63-72.
- Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B, Salvatore D, Reiter D, DiMuzio P. A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg. 2018 Dec;68(6):1744-1752.
- Law A L Krebs B. Karnik B. Griffin L. Comparison of Healthcare Costs Associated With Patients Receiving Traditional Negative Pressure Wound Therapies in the Post Acute Setting. Cureus 12(11): e11790. DOI 10.7759/cureus.11790.
- Page JC, Newsander B, Schwenke DC, Hansen M, Ferguson J. Retrospective analysis of negative pressure wound therapy in open foot wounds with significant soft tissue defects. Adv Skin Wound Care/ 2004;17(7):354-364.
- Baharestani MM. Driver VR. Optimizing clinical and cost effectiveness with early intervention of V.A.C.® Therapy. Ostomy Wound Manage. 2008;54(11 Suppl):1-15.
- Kim PJ, Lookess S, Bongards C, Griffin LP, Gabriel A. Economic model to estimate cost of negative pressure wound therapy with instillation vs control therapies for hospitalised patients in the United States, Germany, and United Kingdom. International Wound Journal. 2022 May;19(4):888-894.
- Cooper HJ, Singh DP, Gabriel A, Mantyh C, Silverman R, Griffin L. Closed Incision Negative Pressure Therapy Versus Standard of Care Over Closed Surgical Incisions in the Reduction of Surgical Site Complications: A Systematic Review and Meta-Analysis of Comparative Studies. Plastic and Reconstructive Surgery – Global Open. 2023 Mar 16;11(3):e4722.
- Berríos-Torres, S. I., Umscheid, C. A., Bratzler, D. W., Leas, B., Stone, E. C., Kelz, R. R., Reinke, C. E., Morgan, S., Solomkin, J. S., Mazuski, J. E., Dellinger, E. P., Itani, K. M., Berbari, E. F., Segreti, J., Parvizi, J., Blanchard, J., Allen, G., Kluytmans, J. A., Donlan, R., & Schecter, W. P. (2017). Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery, 152(8), 784. https://doi.org/10.1001/jamasurg.2017.0904
- Ban, K. A., Minei, J. P., Laronga, C., Harbrecht, B. G., Jensen, E. H., Fry, D. E., Itani, K. M. F., Dellinger, P. E., Ko, C. Y., & Duane, T. M. (2017). American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 update. Journal of the American College of Surgeons, 224(1), 59–74. https://doi.org/10.1016/j.jamcollsurg.2016.10.029